Stay updated with breaking news from Dan Legault. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antibe Therapeutics Inc. today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug Administration that otenaproxesul has been placed on clinical...
It’s stock has been on a roll, but Paradigm Capital analyst Scott McAuley thinks there is still money to be made on Antibe Therapeutics
TORONTO--(BUSINESS WIRE)--$ATBPF--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, is extending the Early Warrant Exercise Incentive Program (“Early Warrant Exercise Program”) for...
TORONTO--(BUSINESS WIRE)--Dec 29, 2023--
Following the company’s Q2, 2024 interim results, Echelon analyst Stefan Quenneville still thinks there is money to be made on Antibe Therapeutics